Four Factors Predict Better Survival With Cabozantinib in mRCC
News: Latest | Digests | Channels | Categories | Gallery
Posted on: December 15, 2020
Category: News , Hematology-Oncology
Four Factors Predict Better Survival With Cabozantinib in mRCC
Starting cabozantinib at 60 mg/day, prior nephrectomy, favorable- or intermediate-risk disease, and BMI of 25 or higher were all significantly associated with better overall survival.
Medscape Medical News
Welcome to the healthcare-only HIPAA - GDPR compliant cloud. Exclusively hosted on a HPC environment!
Learn more or start today by choosing your secure HIPAA - GDPR compliant server's Operating System bellow and pick the package that's best for you.
BIPmd makes it simple to launch in the cloud and scale up as you grow – whether you’re running one virtual machine, thousand or more.
Looking for a custom solution?
Our technicians can provide you with the best custom-made solutionss on the market, no matter whether you're a small business or large enterprise.
Get in touch